ALZHEIMER'S DISEASE AND THE MECHANISMS OF MEMORY LOSS

Alzheimer’s disease AD is a chronic neurodegenerative condition characterized by progressive cognitive decline, particularly affecting memory. This disorder involves complex molecular and cellular changes in the brain, including the accumulation of amyloid-beta plaques, abnormal tau protein formations, loss of synaptic connections, oxidative stress, and inflammatory responses. These pathological events disrupt normal neuronal communication and contribute to the gradual deterioration of memory and other cognitive functions. Understanding the mechanisms behind memory impairment in AD is essential for developing new therapeutic approaches and improving patient care. This review summarizes current knowledge on the biological processes that lead to memory loss in Alzheimer’s disease and highlights potential targets for intervention.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-10-15
DOI
https://doi.org/10.5281/zenodo.17357269
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ALZHEIMER'S DISEASE AND THE MECHANISMS OF MEMORY LOSS

Zenodo (CERN European Organization for Nuclear Research)
Alzheimer's disease research and treatments
article

ALZHEIMER'S DISEASE AND THE MECHANISMS OF MEMORY LOSS

article en

Abstract

Alzheimer’s disease AD is a chronic neurodegenerative condition characterized by progressive cognitive decline, particularly affecting memory. This disorder involves complex molecular and cellular changes in the brain, including the accumulation of amyloid-beta plaques, abnormal tau protein formations, loss of synaptic connections, oxidative stress, and inflammatory responses. These pathological events disrupt normal neuronal communication and contribute to the gradual deterioration of memory and other cognitive functions. Understanding the mechanisms behind memory impairment in AD is essential for developing new therapeutic approaches and improving patient care. This review summarizes current knowledge on the biological processes that lead to memory loss in Alzheimer’s disease and highlights potential targets for intervention.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 41%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.